IMCR

Immunocore Holdings
IMCR

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.49B
EV
$1.10B
Shares Outstanding
50.08M
Beta
0.76

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$62.75
P/E 2025E
-
P/Revenue 2025E
4.15x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Immunocore Holdings plc

gainify
IMCR

Immunocore Holdings plc

IMCR

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic...

Sector

Healthcare

Industry

Biotechnology

CEO

Jallal, Bahija

Employees

493

IPO Date

2021-02-05

Headquarters

92 Park Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RY, United Kingdom

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved